2-hydroxy-5-(morpholin-4-ylsulfonyl)benzoic acid, 95.0%, 5g

Methyl 3-bromo-4-ethoxybenzoate, 95.0%, 5g

8-Hydroxy-7-iodoquinoline-5-sulfonic acid, 95.0%, 5g

2-chloro-5-(methylthio)pyrimidine, 95.0%, 100mg

(3S,5S)-3,5-Dimethylmorpholine hydrochloride, 95.0%, 5g

Methyl 1-methylpyrrole-2-carboxylate, 98.0%, 1g

2-(methylthio)pyrimidine-5-carbaldehyde, 95.0%, 5g

2,2-Difluoro-1-methylcyclopropanecarboxylic acid, 95.0%, 5g

2,4-Dibromothiazole-5-carboxaldehyde, 95.0%, 1g

(5-BROMO-2-HYDROXYPHENYL)(3,5-DIMETHOXYPHENYL)METHANONE, 95.0%, 250mg

Benzamide, N-[3-(dimethylamino)propyl]-4-(8-hydroxy-6-quinolinyl)-, 98%, 5mg

(S)-tert-Butyl 1-(3-chlorobenzyl)pyrrolidin-3-ylcarbamate, 95.0%, 1g

Anti-Human IgG Fc C-terminus Monoclonal Antibody1vial